Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease-Reference-Cited by-同舟云学术

Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease

Published:2015-07-03 Issue:3 Volume:17 Page:326-332
ISSN:1535-1084
Container-title:NeuroMolecular Medicine
language:en
Short-container-title:Neuromol Med

Author:

Forlenza Orestes Vicente,Diniz Breno Satler,Teixeira Antonio Lucio,Radanovic Marcia,Talib Leda Leme,Rocha Natalia Pessoa,Gattaz Wagner Farid

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12017-015-8361-y.pdf

Reference33 articles.

1. Alvarez, X. A., Cacabelos, R., Sampedro, C., Aleixandre, M., Linares, C., Granizo, E., et al. (2011). Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer’s disease: Results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin. European Journal of Neurology, 18, 59–68.

2. Angelucci, F., Spalletta, G., di Iulio, F., Ciaramella, A., Salani, F., Colantoni, L., et al. (2010). Alzheimer’s disease (AD) and mild cognitive impairment (MCI) patients are characterized by increased BDNF serum levels. Current Alzheimer Research, 7, 15–20.

3. Blasko, I., Lederer, W., Oberbauer, H., Walch, T., Kemmler, G., Hinterhuber, H., et al. (2006). Measurement of thirteen biological markers in CSF of patients with Alzheimer’s disease and other dementias. Dementia and Geriatric Cognitive Disorders, 21, 9–15.

4. Brunoni, A. R., Lopes, M., & Fregni, F. (2008). A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: Implications for the role of neuroplasticity in depression. International Journal of Neuropsychopharmacology, 11, 1169–1180.

5. Christensen, R., Marcussen, A. B., Wortwein, G., Knudsen, G. M., & Aznar, S. (2008). A beta(1–42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels. Experimental Neurology, 210, 164–171.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aging-Related Protein Alterations in the Brain;Journal of Alzheimer's Disease;2024-04-22

2. Normal-Tension Glaucoma and Potential Clinical Links to Alzheimer’s Disease;Journal of Clinical Medicine;2024-03-27

3. Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence;Nutrition & Metabolism;2024-03-19

4. Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle;Ageing Research Reviews;2024-03

5. Neurotrophin growth factors and their receptors as promising blood biomarkers for Alzheimer’s Disease: a gene expression analysis study;Molecular Biology Reports;2024-01-02